Andrea Kendell, CFO, North America, VP Finance for Global Mfg, Quality & Supply Chain currently provides oversight and leadership to the company’s Finance and Accounting and Inventory Control teams for North America and Canada in a region representing over $1B in annual revenues. In addition, she leads the finance teams responsible for finance and controlling of 16 manufacturing sites globally. Andrea has been with BioFire Diagnostics/bioMérieux for 8 years and has been a key contributor in leading the company to 20X revenue and 5X growth in headcount and has led several critical construction and key business system projects to facilitate the growth of the company during this time.

From January 2020 to September 2020, Andrea served as the interim CEO while continuing her CFO role for BioFire Diagnostics. Prior to this role, Andrea served as the CFO at BioFire Diagnostics responsible for the oversight and leadership to the company’s Finance and Accounting, Facilities, Human Resources and Inventory Control teams.

Prior to joining BioFire Diagnostics, Ms. Kendell held several positions within Myrexis, Inc., a NASDAQ-listed biotechnology company, including being appointed as Chief Financial Officer, Treasurer and Secretary from September 2011 to February 2013. Ms. Kendell joined Myrexis, Inc. in May 2009 as Corporate Controller and became Vice President, Finance and Human Resources in June 2010.

Prior to joining Myrexis, Ms. Kendell held senior management positions with Moog Medical Devices Group, formerly ZEVEX, Inc., a publicly traded international medical device manufacturing company serving as Corporate Controller from January 1997 to March 2007, and Group Financial Manager from March 2007 to May 2009. Ms. Kendell received a Bachelor degree in Accounting and a Masters of Accounting from Westminster College, Salt Lake City, Utah.